Editas Medicine Inc. (EDIT)
$7.11
Editas Medicine Inc. (EDIT) Share Price Forecast
Currently 25 wall-street analysts regularly analyze the financials of Editas Medicine Inc. on a frequent basis to provide recommendations along with target share price. 25 analysts offering 12-month price forecasts for Editas Medicine Inc. (EDIT) have a share price target of $13.13. This median of share price forecast represents a 84.67% upside from the latest price of $7.11 as on 29.09.23.
Editas Medicine Inc. (EDIT) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Editas Medicine Inc. (EDIT) share price will touch around $13.13 in next 12-months.
Editas Medicine Inc. (EDIT) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Editas Medicine Inc.'s share price and its median forecast price. As on 29.09.23, the difference is -30.85%
Editas Medicine Inc. (EDIT): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Editas Medicine Inc. (EDIT) Share Price : Analyst Recommendation
Based on 25 analysts tracking and researching Editas Medicine Inc. (EDIT) share have hold recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 9 |
| Outperform | 3 | 3 | 3 |
| Hold | 12 | 12 | 11 |
| Underperform | 0 | 0 | 0 |
| Sell | 3 | 3 | 2 |
Editas Medicine Inc. (EDIT) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Editas Medicine Inc. (EDIT) is $13.13, offered by 25 analysts offering 12-month price forecasts.
Editas Medicine Inc. (EDIT) has a maximum of 0.85 upside potential, based on 25 analysts offering 12-month price forecasts.
Based on 25 analysts tracking and researching Editas Medicine Inc. (EDIT), 44% have a hold recommendation. Remaining 56% have either buy or sell recommendations.
The latest share price of Editas Medicine Inc. (EDIT) is $7.11 as of 29/09/2023.
11 of total 25 analysts offering stock ratings for Editas Medicine Inc. EDIT have recommended hold rating.
₹0 US Stocks a/c Opening Fee